LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10053-1 | ZSTK474 | LSM-1053 | 11647372 | ||
10109-1 | YM 201636 | Kin001-170 | LSM-1109 | 9956222 | |
10149-1 | Y39983 | LSM-1150 | 9810884 | ||
10091-1 | XMD16-144 | LSM-43287 | |||
10087-1 | XMD11-85h | LSM-5577 | |||
10086-1 | XMD11-50 | LRRK2-in-1 | LSM-1086 | 46843906 | |
10148-1 | XL147 | SAR245408 | LSM-1149 | 52914932 | |
10082-1 | WZ-4-145 | LSM-5545 | |||
10084-1 | WZ3105 | LSM-5970 | 42628507 | ||
10064-1 | WYE-125132 | LSM-1064 | 25260757 | ||
10481-1 | Withaferin A | NSC 273757; NSC-101088 | LSM-6685 | 265237 | |
10039-1 | WH-4-025 | LSM-44937 | |||
10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 | 42611257 | |
10111-1 | TWS119 | LSM-1111 | 9549289 | ||
10142-1 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10021-1 | Tozasertib | VX680; MK-0457 | LSM-1021 | 5494449 | |
10080-1 | Torin2 | LSM-1080 | 51358113 | ||
10079-1 | Torin1 | LSM-1079 | 49836027 | ||
10171-1 | TGX221 | LSM-1172 | 9907093 | ||
10119-1 | SU11274 | PKI-SU11274 | LSM-42791 | 53396327 | |
10008-1 | Sorafenib | BAY-439006 | LSM-1008 | 216239 | |
10132-1 | SNS-032 | BMS-387032 | LSM-1132 | 3025986 | |
10052-1 | Sirolimus | Rapamycin | LSM-1052 | 5040 | |
10035-1 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 | 10196499 | |
10056-1 | Selumetinib | AZD6244; Array142886 | LSM-1056 | 10127622 |